NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like <b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017 Why This Maryland Biotech Could Double Its Stock by 2018 November 19, 2017 4 Top-Performing S&P 500 Biotech Stocks of 2017 December 27, 2017
<b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017
